PEGINTERFERON ALFA-2A [40KD] PLUS ADEFOVIR FOR 96 WEEKS IN HBEAG-NEGATIVE CHB RESULTS IN HIGH RATES OF HBSAG CLEARANCE/SEROCONVERSION

被引：1
|
作者：
Cao, Z. [1 ]
Yu, H. [1 ]
Ma, L. [1 ]
Zhang, Y. [1 ]
Liu, Y. [1 ]
Ma, B. [1 ]
Wu, H. [1 ]
Chen, X. [1 ]
机构：
[1] Beijing Youan Hosp, Beijing, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60707-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
705
引用
收藏
页码：S283 / S283
页数：1
相关论文
共 50 条
  • [41] High response rates with peginterferon alfa-2a (40KD) (Pegasys®) plus ribavirin (Copegus®) in Japanese non-responders or relapsers to conventional interferon
    Izumi, Namiki
    Iino, Shiro
    Okuno, Tadao
    Omata, Massao
    Kiyosawa, Kendo
    Kumada, Hiromitsu
    Hayashi, Norio
    Yamada, Gotaro
    Sakai, Takahiro
    GASTROENTEROLOGY, 2006, 130 (04) : A841 - A842
  • [42] COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON ALFA-2A (40KD) IN HBEAG-POSITIVE CHRONIC HEPATITIS B IN POLAND
    Jakubczyk, M.
    Paweska, J.
    Niewada, M.
    Berak, H.
    Szkultecka-Debek, M.
    Russel-Szymczyk, M.
    VALUE IN HEALTH, 2011, 14 (07) : A275 - A275
  • [43] HBSAG LEVELS DECLINE DURING PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B FAVORS 6 MONTHS POST-TREATMENT RESPONSE: PERSEAS COHORT INTERIM ANALYSIS
    Goulis, I.
    Akriviadis, E.
    Karatapanis, S.
    Deutsch, M.
    Dalekos, G.
    Raptopoulou-Gigi, M.
    Mimidis, K.
    Germanidis, G.
    Triantos, C.
    Drakoulis, C.
    Chounta, A.
    Tsoplou, F.
    Zintzaras, E.
    Bakalos, G.
    Papatheodoridis, G.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S201 - S202
  • [44] Responses to peginterferon alfa-2a (40 KD) (PEGASYS) treatment are durable in Asian patients with HBeAg-negative CHB: 12 month follow-up data from a large randomised study
    Marcellin, Patrick
    Lau, George K. K.
    Piratvisuth, Teerha
    Jin, Rui
    Lu, Zhi-Meng
    Lai, Ming-Yang
    Thongsawat, Satawat
    Ramakrishnan, Balu
    Popescu, Matei
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A140 - A141
  • [45] Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients
    Nelson, David R.
    Zeuzem, Stefan
    Andreone, Pietro
    Ferenci, Peter
    Herring, Robert
    Jensen, Donald M.
    Marcellin, Patrick
    Pockros, Paul J.
    Rodriguez-Torres, Maribel
    Rossaro, Lorenzo
    Rustgi, Vinod K.
    Sepe, Thomas
    Sulkowski, Mark
    Thomason, Isaac R.
    Yoshida, Eric M.
    Chan, Anna
    Hill, George
    ANNALS OF HEPATOLOGY, 2012, 11 (01) : 15 - 31
  • [46] Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Hepatitis C Patients with Advanced Fibrosis and Cirrhosis
    Bruno, Savino
    Shiffman, Mitchell L.
    Roberts, Stuart K.
    Gane, Edward J.
    Messinger, Diethelm
    Hadziyannis, Stephanos J.
    Marcellin, Patrick
    HEPATOLOGY, 2010, 51 (02) : 388 - 397
  • [47] Peginterferon Alfa-2a (40KD) Plus Lamivudine or Entecavir in Children With Immune-Tolerant Chronic Hepatitis B
    Mieli-Vergani, Giorgina
    Bansal, Sanjay
    Daniel, James F.
    Kansu, Aydan
    Kelly, Deirdre
    Martin, Carmen
    Tizzard, Sarah
    Wirth, Stefan
    Zhou, Julian
    Vergani, Diego
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 73 (02): : 156 - 160
  • [48] Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
    Peng, C. -Y.
    Lai, H. -C.
    Li, Y. -F.
    Su, W. -P.
    Chuang, P. -H.
    Kao, J. -T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (04) : 458 - 468
  • [49] Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
    Rijckborst, Vincent
    Hansen, Bettina E.
    Ferenci, Peter
    Brunetto, Maurizia R.
    Tabak, Fehmi
    Cakaloglu, Yilmaz
    Lanza, A. Galeota
    Messina, Vincenzo
    Iannacone, Claudio
    Massetto, Benedetta
    Regep, Loredana
    Colombo, Massimo
    Janssen, Harry L. A.
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2012, 56 (05) : 1006 - 1011
  • [50] A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirin
    Ferenci, Peter
    Aires, Rodrigo
    Ancuta, Ioan
    Arohnson, Andrew
    Cheinquer, Hugo
    Delic, Dragan
    Gschwantler, Michael
    Larrey, Dominique
    Tallarico, Ludovico
    Schmitz, Manuela
    Tatsch, Fernando
    Ouzan, Denis
    LIVER INTERNATIONAL, 2014, 34 (10) : 1550 - 1559
12345